{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:13:40Z","timestamp":1782123220141,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["R01DA019497"],"award-info":[{"award-number":["R01DA019497"]}]},{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["T32DA07209"],"award-info":[{"award-number":["T32DA07209"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.drugalcdep.2018.12.026","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T12:12:14Z","timestamp":1550146334000},"page":"220-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial"],"prefix":"10.1016","volume":"197","author":[{"given":"Brantley P.","family":"Jarvis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August F.","family":"Holtyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"DeFulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail N.","family":"Koffarnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie-Marie S.","family":"Leoutsakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6153-5680","authenticated-orcid":false,"given":"Annie","family":"Umbricht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fingerhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Bigelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2724-1413","authenticated-orcid":false,"given":"Kenneth","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2011.10.018","article-title":"Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose\u2013effects and time-course","volume":"123","author":"Bigelow","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0376-8716(96)01249-5","article-title":"Comparing assessments of DSMIV substance dependence disorders using CIDI-SAM and SCAN","volume":"41","author":"Compton","year":"1996","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0015","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ypmed.2012.04.017","article-title":"The use of incentives to reinforce medication adherence","volume":"55","author":"DeFulio","year":"2012","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2011.06.023","article-title":"Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial","volume":"120","author":"DeFulio","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/a0030743","article-title":"Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users","volume":"21","author":"Dunn","year":"2013","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0030","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamainternmed.2017.2158","article-title":"Financial incentives for linkage to care and viral suppression among HIV-positive patients: a randomized clinical trial (HPTN 065)","volume":"177","author":"El-Sadr","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0035","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1360-0443.2011.03400.x","article-title":"Employment\u2010based reinforcement of adherence to depot naltrexone in unemployed opioid\u2010dependent adults: A randomized controlled trial","volume":"106","author":"Everly","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0040","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1414293","article-title":"Randomized trial of four financial-incentive programs for smoking cessation","volume":"372","author":"Halpern","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0045","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003\u20132013","volume":"314","author":"Han","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0050","series-title":"Wisconsin Card Sorting Test Manual Revised and Expanded","author":"Heaton","year":"1993"},{"issue":"4","key":"10.1016\/j.drugalcdep.2018.12.026_bib0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jaba.158","article-title":"Employment\u2010based abstinence reinforcement promotes opiate and cocaine abstinence in out\u2010of\u2010treatment injection drug users","volume":"47","author":"Holtyn","year":"2014","journal-title":"J. Appl. Behav. Anal."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0060","article-title":"Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults","author":"Jarvis","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0065","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/add.13724","article-title":"Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults","volume":"112","author":"Jarvis","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0070","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsat.2016.12.006","article-title":"Factors associated with using opiates while under extended-release naltrexone blockade: a descriptive pilot study","volume":"85","author":"Jarvis","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0080","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users - United States, 2002-2013","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0085","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicenter randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0197-2456(88)90049-9","article-title":"Randomization in clinical trials: conclusions and recommendations","volume":"9","author":"Lachin","year":"1988","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0095","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1037\/1076-898X.8.2.75","article-title":"Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART)","volume":"8","author":"Lejuez","year":"2002","journal-title":"J. Exp. Psychol. Appl."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0110","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0115","series-title":"Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence","author":"Mattick","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the Addiction Severity Index. Reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archpsyc.63.2.201","article-title":"Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a national drug abuse treatment clinical trials network study","volume":"63","author":"Peirce","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.39265.639641.AD","article-title":"NICE. Psychosocial interventions and opioid detoxification for drug misuse: Summary of NICE guidance","volume":"335","author":"Pilling","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0135","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: a meta\u2010analysis","volume":"101","author":"Prendergast","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0376-8716(01)00160-0","article-title":"Voucher-based reinforcement of opiate abstinence during methadone detoxification","volume":"65","author":"Robles","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0145","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014united States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0150","series-title":"Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction","author":"SAMHSA","year":"2019"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1037\/1064-1297.9.1.14","article-title":"A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes","volume":"9","author":"Silverman","year":"2001","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0145445504272600","article-title":"A web-based therapeutic workplace for the treatment of drug addiction and chronic unemployment","volume":"29","author":"Silverman","year":"2005","journal-title":"Behav. Modif."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0165","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0170","series-title":"Facing Addiction in America: the Surgeon General\u2019s Report on Alcohol, Drugs, and Health","author":"US Department of Health and Human Services","year":"2016"},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0175","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid- overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.12.026_bib0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMsa0806819","article-title":"A randomized, controlled trial of financial incentives for smoking cessation","volume":"360","author":"Volpp","year":"2009","journal-title":"N. Engl. J. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618304927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618304927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:56:01Z","timestamp":1759827361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618304927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":36,"alternative-id":["S0376871618304927"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.12.026","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}